Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
Clinical trial NCT02866565 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02866565
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2026-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.